Human Serpin A12/Vaspin antibody

Visceral adipose tissue-derived serine protease inhibitor, SERPINA12, Serpin peptidase inhibitor clade A member 12, Serpin A12 precursor, Serine (or cysteine) proteinase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 12, OL-64, ENSG0000016595

Visceral adipose tissue-derived serine protease inhibitor, Visceral adipose tissue derived serine protease inhibitor, SERPINA12, SERPINA 12, Serpin peptidase inhibitor clade A member 12, Serpin A12 precursor, Serpin A12, Serine proteinase inhibitor clade A member 12, Serine proteinase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 12, Serine proteinase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12, Serine (or cysteine) proteinase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 12, Serine (or cysteine) proteinase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12, OL-64, OL64, OL 64, ENSG00000165953, Cysteine proteinase inhibitor clade A member 12, Cysteine proteinase inhibitor clade A (alpha-1 antiproteinase antitrypsin) member 12, Cysteine proteinase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 12, AVA0721-10 µg, AVA0721-20 µg, AVA0721-50 µg, AVA0721-100 µg, AVA0721-250 µg, AVA0721-500 µg, AVA0721-1 mg, AVA0721-01

The antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended dilution range for Western blot analysis is 1:1,000 ~ 3,000. Recommended starting dilution is 1:2,000.

The cell lysates (10 µg) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human Vaspin antibody (1:1000) . Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system. ; ; Lane 1.: 293T cell lysate ; ; Lane 2.: Vaspin transfected 293T cell lysate